Valeo Pharma Inc. (VPHIF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 11, 2026
Valeo Pharma Employees
Valeo Pharma had 70 employees as of July 31, 2024. The number of employees decreased by 55 or -44.00% compared to the same quarter last year.
Employees
70
Change
-55
Growth
-44.00%
Revenue / Employee
$552,025
Profits / Employee
-$332,185
Market Cap
99.00
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jul 31, 2024 | 70 | -55 | -44.00% |
| Apr 30, 2024 | 80 | -45 | -36.00% |
| Jan 31, 2024 | 100 | -20 | -16.67% |
| Oct 31, 2023 | 110 | -5 | -4.35% |
| Jul 31, 2023 | 125 | 25 | 25.00% |
| Apr 30, 2023 | 125 | 25 | 25.00% |
| Jan 31, 2023 | 120 | 20 | 20.00% |
| Oct 31, 2022 | 115 | 15 | 15.00% |
| Jul 31, 2022 | 100 | -5 | -4.76% |
| Apr 30, 2022 | 100 | 25 | 33.33% |
| Jan 31, 2022 | 100 | 62 | 163.16% |
| Oct 31, 2021 | 100 | 62 | 163.16% |
| Jul 31, 2021 | 105 | 78 | 288.89% |
| Apr 30, 2021 | 75 | 48 | 177.78% |
| Jan 31, 2021 | 38 | 11 | 40.74% |
| Oct 31, 2020 | 38 | 11 | 40.74% |
| Jul 31, 2020 | 27 | 0 | - |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Valeo Pharma News
- 3 years ago - VALEO PHARMA ENTERS INTO CANADIAN COMMERCIAL SERVICES AGREEMENT WITH VERU FOR SABIZABULIN IN HOSPITALIZED ADULT PATIENTS WITH COVID-19 AT HIGH RISK FOR ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) - PRNewsWire
- 4 years ago - VALEO PHARMA OBTAINS PUBLIC REIMBURSEMENT FOR ENERZAIR® BREEZHALER® AND ATECTURA® BREEZHALER® IN ONTARIO, MANITOBA AND NEW BRUNSWICK - PRNewsWire
- 4 years ago - VALEO PHARMA'S HESPERCO™ NOW AVAILABLE AT LOBLAWS, HESPERIDIN COVID-19 CLINICAL TRIAL RESULTS SUBMITTED FOR PUBLICATION - PRNewsWire
- 4 years ago - Valeo Pharma Announces Upsize of Previously Announced Bought Deal Private Placement of Convertible Debentures to $15 Million With Concurrent $10 Million Private Placement From Investissement Quebec - GlobeNewsWire
- 4 years ago - Valeo Pharma Announces $10 Million Bought Deal Private Placement of Convertible Debentures With Concurrent $10 Million Private Placement From Investissement Quebec - GlobeNewsWire
- 4 years ago - Valeo Pharma Obtains Public Reimbursement For Enerzair® Breezhaler® and Atectura® Breezhaler® In Alberta - PRNewsWire
- 4 years ago - /C O R R E C T I O N from Source -- Valeo Pharma inc./ - PRNewsWire
- 4 years ago - Valeo Pharma Obtains Listings for Redesca in 700 Hospitals and Healthcare Facilities Across Canada - PRNewsWire